Insulin Deficiency Exacerbates Muscle Atrophy and Osteopenia in Chrebp Knockout Mice

Area of Science:

• Endocrinology
• Metabolic Diseases
• Bone and Muscle Biology

Background:

• Type 1 diabetes mellitus is linked to sarcopenia and osteoporosis due to impaired glucose utilization and insulin signaling.
• Insulin and glucose signaling deficits accelerate muscle and bone health decline.

Purpose of the Study:

• To investigate if insulin deficiency exacerbates muscle and bone deterioration in Chrebp knockout mice.
• To understand the interplay between ChREBP deficiency, insulin deficiency, and musculoskeletal health.

Main Methods:

• Male wild-type (WT) and Chrebp knockout (KO) mice were induced with insulin deficiency using streptozotocin (STZ).
• Body weight, muscle weight, grip strength, IGF-1 expression, Atrogin mRNA levels, and bone mineral density (BMD) were assessed.

Main Results:

• STZ-treated KO mice showed greater reductions in body weight and muscle mass compared to WT mice.
• Grip strength and IGF-1 expression decreased, while Atrogin mRNA levels increased more significantly in STZ-treated KO mice.
• STZ administration reduced BMD specifically in the KO group, whereas WT mice showed no significant BMD decrease.

Conclusions:

• ChREBP deficiency exacerbates insulin deficiency-induced sarcopenia and osteoporosis.
• Insulin and glucose signaling are crucial for maintaining muscle and bone mass and function.
• Further research is needed to clarify the mechanisms underlying ChREBP deletion and insulin deficiency-induced osteosarcopenia.